WHAT WE DO
WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $4 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
 
OUR AREAS
INVESTMENT MANAGEMENT

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

m&a AND STRATEGIC ADVISORY

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.  

INVESTMENT BANKING

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.  

institutional sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

equity research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

EQUITY Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

PRESS RELEASES

VIEW ALL

WBB Securities Acts as Co-manager for $300 Million Public Offering for Sarepta Therapeutics

WBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.
CONTINUE READING

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
CONTINUE READING

WBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference

WBB Securities is a sponsor of this year’s Future Leader’s conference.
CONTINUE READING

OPINIONS & FEATURES

VIEW ALL

How Mylan And Pfizer Could Cause A Major Biotech Backlash

You know you’re in the middle of a crisis when Martin Shkreli defends your pharmaceutical company’s price hikes.
CONTINUE READING

Brexit Will Be Bad For Pharma

In medicine they talk about triage in making quick decisions to save lives. Central bankers and politicians across Europe will…
CONTINUE READING

Superbug Hearing: Will Congress Pick Up Ali’s Fight Against Sepsis?

During his life, Muhammad Ali did many great things for a great many people. But he may still have another…
CONTINUE READING